Respiratory Infections News

Wastewater surveillance can effectively detect upticks in viral respiratory infections, which could help identify outbreaks, another study has shown.

A recombinant influenza vaccine offered additional protection against PCR-confirmed influenza and community-acquired pneumonia hospitalization among adults aged 50 to 64 years compared with a standard-dose vaccine, study results showed.

The incidence of hospital-associated respiratory virus infections was higher among pediatric patients compared with adult patients, according to a study of patients at University of Michigan hospitals.

Moderna’s messenger RNA-based respiratory syncytial virus vaccine is safe and effective for older adults, according to phase 3 trial data.

Influenza vaccine efficacy during the 2022-2023 influenza season was “moderate” but still prevented many health care encounters and hospitalizations among adult patients, researchers determined.

The U.K. Medicines and Healthcare products Regulatory Agency recently approved a phase 1 study that will test an inhaled mRNA-based drug as a treatment and prophylaxis of respiratory viral infections, according to a press release.

In a survey of health care personnel, one-third of registered nurses and more than one-quarter of physicians reported making at least one error in adhering to guidance for personal protective equipment in the previous 2 weeks.

For the past 5 years, we have asked infectious disease clinicians to tell us when and why they chose a career in ID.

Long COVID can be difficult for primary care physicians to manage, but they are in a unique position to provide the best care for the condition, according to experts.

Children who received two or more doses of COVID-19 messenger RNA vaccine were 40% less likely to be hospitalized or visit an ED due to the disease, according to findings published in MMWR.